These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15457481)

  • 1. Radiographic progression in early rheumatoid arthritis: comment on the article by Goronzy et al.
    Sanmarti R; Gómez-Centeno A; Gratacós J; Cañete JD
    Arthritis Rheum; 2004 Sep; 50(9):3052-3; author reply 3053-4. PubMed ID: 15457481
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
    Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F
    Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353
    [No Abstract]   [Full Text] [Related]  

  • 3. Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al.
    Kirwan JR
    Arthritis Rheum; 1999 May; 42(5):1066-7. PubMed ID: 10323469
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al.
    Graudal N; Jürgens G
    Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between clinical response to treatment and radiographic progression: comment on the article by Strand and Sharp.
    Rau R
    Arthritis Rheum; 2003 Oct; 48(10):2997-8; author reply 2998. PubMed ID: 14558112
    [No Abstract]   [Full Text] [Related]  

  • 6. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.
    Rau R; Wassenberg S
    J Rheumatol; 1999 Oct; 26(10):2280-1. PubMed ID: 10529157
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
    van Riel PL; van der Heijde DM; Nuver-Zwart IH; van de Putte LB
    J Rheumatol; 1995 Sep; 22(9):1797-9. PubMed ID: 8523366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: comment on the article by Graudal et al.
    Landewé R; Gorter S; Gaujoux-Viala C; Gossec L; Smolen JS
    Arthritis Rheum; 2011 Oct; 63(10):3182-4; discussion 3184-6. PubMed ID: 21702017
    [No Abstract]   [Full Text] [Related]  

  • 9. Rheumatoid arthritis: radiographic progression is getting milder.
    Krishnan E; Fries JF
    J Rheumatol; 2005 Jan; 32(1):195; author reply 195. PubMed ID: 15630753
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.
    Yazici Y; Yazici H
    Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic progression in rheumatoid arthritis: does it still happen and does it matter?
    Bykerk VP
    J Rheumatol; 2014 Dec; 41(12):2337-9. PubMed ID: 25452176
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate and radiographic disease progression in patients with rheumatoid arthritis.
    Kremer JM
    J Rheumatol; 1999 Feb; 26(2):241-3. PubMed ID: 9972951
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic markers of radiographic progression in early rheumatoid arthritis.
    Goronzy JJ; Matteson EL; Fulbright JW; Warrington KJ; Chang-Miller A; Hunder GG; Mason TG; Nelson AM; Valente RM; Crowson CS; Erlich HA; Reynolds RL; Swee RG; O'Fallon WM; Weyand CM
    Arthritis Rheum; 2004 Jan; 50(1):43-54. PubMed ID: 14730598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.
    Strand V; Landéwé R; van der Heijde D
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii64-6. PubMed ID: 12379626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of rheumatoid arthritis (RA) with anticytokines].
    Feuchtenberger M; Kneitz C; Tony HP
    MMW Fortschr Med; 2006 Oct; 148(42):44-5, 47. PubMed ID: 17621799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia to predict radiographic progression in rheumatoid arthritis.
    van Steenbergen HW; van Nies JA; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 Jul; 72(7):e16. PubMed ID: 23625976
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarkers in the prediction of radiographic progression in early rheumatoid arthritis: comment on the article by Young-Min et al.
    Tchetverikov I; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2008 May; 58(5):1558-9; author reply 1559. PubMed ID: 18438824
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
    Finckh A; Liang MH; van Herckenrode CM; de Pablo P
    Arthritis Rheum; 2006 Dec; 55(6):864-72. PubMed ID: 17139662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al.
    Seitz M; Villiger PM
    Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.